Precision Biosciences annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
Precision Biosciences Revenue Growth & History (DTIL)
Precision Biosciences reported $34.3M in revenue for fiscal 2025, a decrease of 50.12% from the previous fiscal year.
View full Precision Biosciences company overviewPrecision Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $34.3M | −$34.4M | −50.12% |
| 2024 | 2024-12-31 | $68.7M | $20.0M | +40.98% |
| 2023 | 2023-12-31 | $48.7M | $23.6M | +94.15% |
| 2022 | 2022-12-31 | $25.1M | −$90.4M | −78.28% |
| 2021 | 2021-12-31 | $115.5M | $91.2M | +375.72% |
| 2020 | 2020-12-31 | $24.3M | $2.0M | +9.20% |
| 2019 | 2019-12-31 | $22.2M | $11.4M | +104.34% |
| 2018 | 2018-12-31 | $10.9M | — | — |
Precision Biosciences quarterly revenue
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$18,000 | −100.00% |
| Q1 2026 | 2026-03-31 | $10.8M | $10.8M | +37272.41% |
| Q4 2025 | 2025-12-31 | $34.2M | $33.6M | +5261.13% |
| Q3 2025 | 2025-09-30 | $13,000 | −$563,000 | −97.74% |
| Q2 2025 | 2025-06-30 | $18,000 | −$49.9M | −99.96% |
| Q1 2025 | 2025-03-31 | $29,000 | −$17.6M | −99.84% |
| Q4 2024 | 2024-12-31 | $638,000 | −$6.4M | −90.93% |
| Q3 2024 | 2024-09-30 | $576,000 | −$12.5M | −95.61% |
| Q2 2024 | 2024-06-30 | $49.9M | $30.1M | +152.15% |
| Q1 2024 | 2024-03-31 | $17.6M | $8.8M | +100.27% |
| Q4 2023 | 2023-12-31 | $7.0M | −$3.6M | −33.59% |
| Q3 2023 | 2023-09-30 | $13.1M | $5.8M | +78.19% |
| Q2 2023 | 2023-06-30 | $19.8M | $16.0M | +418.04% |
| Q1 2023 | 2023-03-31 | $8.8M | $5.5M | +164.70% |
| Q4 2022 | 2022-12-31 | $10.6M | $4.3M | +67.19% |
| Q3 2022 | 2022-09-30 | $7.4M | −$16.7M | −69.37% |
| Q2 2022 | 2022-06-30 | $3.8M | −$65.0M | −94.45% |
| Q1 2022 | 2022-03-31 | $3.3M | −$13.0M | −79.71% |
| Q4 2021 | 2021-12-31 | $6.3M | −$2.5M | −28.34% |
| Q3 2021 | 2021-09-30 | $24.0M | $16.7M | +226.44% |
| Q2 2021 | 2021-06-30 | $68.8M | $67.7M | +6282.65% |
| Q1 2021 | 2021-03-31 | $16.3M | $9.4M | +133.62% |
| Q4 2020 | 2020-12-31 | $8.8M | $2.3M | +35.63% |
| Q3 2020 | 2020-09-30 | $7.4M | $2.5M | +51.35% |
| Q2 2020 | 2020-06-30 | $1.1M | −$4.3M | −80.00% |
| Q1 2020 | 2020-03-31 | $7.0M | $1.5M | +28.12% |
| Q4 2019 | 2019-12-31 | $6.5M | $1.6M | +32.02% |
| Q3 2019 | 2019-09-30 | $4.9M | $2.3M | +91.46% |
| Q2 2019 | 2019-06-30 | $5.4M | $3.5M | +187.57% |
| Q1 2019 | 2019-03-31 | $5.5M | $3.9M | +257.46% |
| Q4 2018 | 2018-12-31 | $4.9M | — | — |
| Q3 2018 | 2018-09-30 | $2.5M | — | — |
| Q2 2018 | 2018-06-30 | $1.9M | — | — |
| Q1 2018 | 2018-03-31 | $1.5M | — | — |
Precision Biosciences revenue growth trends
Over the last five reported fiscal years, revenue grew from $24.3M to $34.3M, a compound annual growth rate of 7.13%. Precision Biosciences's latest reported quarter, Q2 2026, generated $0 in revenue, a decrease of 100.00% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Precision Biosciences source filings ↗